Refractoriness to eltrombopag in adult primary immune thrombocytopenia: utility of next-generation sequencing techniques

Refractoriness to eltrombopag in adult primary immune thrombocytopenia: utility of next-generation sequencing techniques

Abstract: Thrombopoietin receptor agonists, for example eltrombopag, are standard second-line treatment for immune thrombocytopenia (ITP). Eltrombopag has demonstrated high response rates, both in clinical trials and in routine practice studies. However, some patients with ITP are refractory to this...

Full description

Saved in:
Bibliographic Details
Main Authors: Tomás José González-López, Ricardo Sanchez, Carmen Pastoriza, Pavel Olivera, Silvia Bernat, Fernando Fernandez-Fuertes, Isabel Socorro Caparrós-Miranda, Gloria Pérez-Rus, Isidro Jarque, Maria Esperanza Moreno-Beltrán, Emma López-Abadía, Erik De Cabo, Shally Marcellini, Gloria Pérez-Segura, Carmen Fernández-Miñano, María Jesús Peñarrubia, Sergio Matarraz, María Pérez-Caro, Alberto Orfao, Drew Provan, Joaquín Martínez-López
Format: Article
Language:English
Published: Elsevier 2025-08-01
Series:Blood Vessels, Thrombosis & Hemostasis
Online Access:http://www.sciencedirect.com/science/article/pii/S295032722500018X
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.sciencedirect.com/science/article/pii/S295032722500018X

Similar Items